What is the pathophysiology of cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Cardiogenic Shock

Cardiogenic shock is a state of inadequate cardiac output resulting from primary myocardial dysfunction, triggering a cascade of maladaptive compensatory mechanisms that perpetuate systemic hypoperfusion, end-organ ischemia, and progressive multiorgan failure. 1

Central Hemodynamic Derangement

The fundamental pathophysiologic defect is marked reduction in cardiac output (cardiac index <2.2 L/min/m²) caused by loss of myocardial contractility, which initiates a vicious cycle of progressive deterioration. 1, 2 This occurs when:

  • At least 40% of left ventricular myocardium is lost or dysfunctional, either from extensive myocardial necrosis or stunned but viable myocardium following acute myocardial infarction. 3, 1
  • The failing myocardium cannot generate adequate stroke volume despite elevated filling pressures (PCWP >15 mmHg, CVP >15 mmHg). 1, 2

The Maladaptive Spiral: Key Pathophysiologic Mechanisms

Impaired Coronary Perfusion and Progressive Myocardial Dysfunction

Progressive diastolic dysfunction raises ventricular end-diastolic pressures, which directly diminishes coronary perfusion pressure, further impairing myocardial contractility and stroke volume in a self-perpetuating cycle. 1 This creates ongoing myocardial ischemia even after initial revascularization in AMI-related shock.

Compensatory Vasoconstriction and Increased Afterload

The body responds to falling cardiac output by activating neurohormonal pathways that trigger systemic vasoconstriction, manifesting as increased systemic vascular resistance (SVR) in an attempt to maintain blood pressure. 1, 2 However, this compensatory mechanism backfires—the increased afterload further impairs the already failing heart, worsening cardiac output and perpetuating the shock state. 2

Inflammatory Cascade and Systemic Vasodilation

Inflammatory mediators released during shock further impair tissue metabolism and stimulate nitric oxide production, causing paradoxical systemic vasodilation that exacerbates hypotension despite the initial vasoconstriction. 1 This inflammatory response contributes to:

  • Progressive endothelial dysfunction
  • Microvascular thrombosis
  • Worsening tissue hypoxia

Pulmonary Dysfunction and Right Ventricular Afterload

Hypoxia and pulmonary inflammation provoke pulmonary vasoconstriction, which increases biventricular afterload and myocardial oxygen demand, further compromising cardiac performance. 1 This mechanism is particularly important in:

  • Right ventricular infarction (most commonly associated with inferior AMI) 3, 1
  • Biventricular shock phenotypes where both RA pressure >15 mmHg and PCWP >15 mmHg 2

Volume Overload from Renal Compensation

Renal hypoperfusion activates sodium reabsorption and the renin-angiotensin-aldosterone system, leading to additional volume overload that worsens ventricular filling pressures and pulmonary congestion. 1 Simultaneously, sympathetically mediated splanchnic vasoconstriction redistributes approximately 50% of total blood volume back into the central circulation, further exacerbating volume overload and compromising cardiac performance. 1

Phenotype-Specific Pathophysiology

Left Ventricular-Dominant Shock

  • PCWP >15 mmHg with RA <15 mmHg produces prominent pulmonary congestion and pulmonary edema from backward failure. 2
  • Manifests with decreased LV ejection fraction, regional wall motion abnormalities, and decreased stroke volume. 3
  • Secondary mitral regurgitation frequently develops, which is a major predictor of mortality. 3

Right Ventricular-Dominant Shock

  • RA pressure >15 mmHg with PCWP <15 mmHg leads to jugular venous distension but relatively clear lung fields. 2
  • Echocardiography demonstrates RV dyssynergy, dilatation, paradoxical septal motion, McConnell sign, and decreased TAPSE. 3
  • Critical pitfall: When right-ventricular assist devices are used, the increased volume delivered to the LV may unmask significant underlying LV dysfunction. 3

Biventricular Shock

  • Both RA >15 mmHg and PCWP >15 mmHg reflecting combined left- and right-heart failure with the worst prognosis. 2

Mechanical Complications with Distinct Pathophysiology

Ventricular Septal Rupture

Creates acute left-to-right shunting with rapid hemodynamic deterioration and volume overload of the right ventricle. 1, 4

Papillary Muscle Rupture

Produces acute severe mitral regurgitation, dramatically reducing forward cardiac output while increasing left atrial and pulmonary pressures. 1, 4

Free Wall Rupture

The most serious complication following AMI, presenting along a spectrum from acute catastrophic collapse with electromechanical dissociation to insidious pericardial effusion with tamponade physiology. 3, 1

End-Organ Consequences

The inadequate cardiac output and systemic hypoperfusion result in:

  • Elevated lactate (>2 mmol/L) from anaerobic metabolism 2
  • Oliguria (<0.5 mL/kg/h) from renal hypoperfusion 4
  • Altered mental status from cerebral hypoperfusion 4
  • Cool extremities from peripheral vasoconstriction 4
  • Hepatic dysfunction with elevated bilirubin (≥1.3 mg/dL independently predicting 180-day cardiac mortality) 2

Common Diagnostic Pitfall

Avoid confusing late-stage septic shock with cardiogenic shock—septic shock can develop myocardial depression, but the primary hemodynamic pattern remains distributive with decreased SVR, whereas cardiogenic shock demonstrates elevated SVR as a compensatory mechanism. 4, 2 Invasive hemodynamic monitoring with pulmonary artery catheterization provides definitive differentiation when diagnosis remains unclear. 4, 2

References

Guideline

Cardiogenic Shock Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiogenic Shock Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the clinical findings in cardiogenic shock?
What are the causes of cardiogenic shock?
What type of shock is a patient with atrial fibrillation (A-fib) and heart failure, presenting with shortness of breath, crackles, weakness, pleural effusion symptoms, and cold and muffled skin, elevated creatine kinase MB (CK MB) and normal troponin 1, most likely experiencing?
What are the primary causes of cardiogenic shock?
What laboratory tests should be ordered for a patient in cardiogenic shock?
What is the initial assessment and management of a patient with musculoskeletal trauma, including ABCs, analgesia, tetanus prophylaxis, immobilization, imaging, antibiotic coverage for open fractures, and definitive orthopedic care?
How should a 1‑month postpartum woman with abdominal/pelvic pain and fever be evaluated and managed?
Should a 27‑year‑old patient with a prior cryptogenic stroke due to a high‑risk patent foramen ovale and atrial septal aneurysm, now showing a low‑grade residual right‑to‑left shunt on transcranial Doppler but no flow on transesophageal echocardiography, undergo repeat percutaneous closure?
Can oseltamivir (Tamiflu) cause QTc prolongation and what monitoring and management steps are recommended for patients at risk (e.g., baseline QTc ≥460 ms, cardiac disease, electrolyte disturbances, or concomitant QT‑prolonging drugs)?
In a patient with known patent ductus arteriosus presenting with cyanosis, irregular heart rhythm, and an S3 gallop, what is the most common cause of clinical deterioration?
Do regular lipsticks protect the lips from ultraviolet (UV) radiation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.